The Anrep effect reconsidered.
Evidence is presented supporting the hypothesis that the positive inotropic effect after an abrupt increase in systolic pressure (Anrep effect) is the recovery from subendocardial ischemia induced by the increase and subsequently corrected by vascular autoregulation of the coronary bed. Major evidence consists of data obtained from an isolated heart preparation showing that the Anrep effect can be abolished with coronary vasodilation, and that with an abrupt increase in systolic pressure there is a significant reduction in the distribution of coronary flow to subendocardial layers of the ventricle. Furthermore, the intracardiac electrocardiogram shows S-T segment and T wave changes after an abrupt increase in ventricular pressure similar to that noted after coronary constriction. Major implications are that normally there may be ischemia of the subendocardial layers tending to reduce myocardial contractility which may account, in part, for the positive inotropic effect of various coronary vasodilators; that with an abrupt increase in ventricular pressure the subendocardium is rendered temporarily ischemic, placing the heart in jeopardy from arrhythmias until this is corrected; and that end-diastolic pressure and the intracardiac electrocardiogram may provide a means of evaluating the adequacy of circulation to subendocardial layers in diseased ventricles when systolic pressure is abruptly increased.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure; D002404:Catheterization; D002564:Cerium Isotopes; D003326:Coronary Circulation; D004285:Dogs; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006352:Heart Ventricles / Q000098:blood supply; D066298:In Vitro Techniques; D008168:Lung; D008433:Mathematics; D009119:Muscle Contraction; D009203:Myocardial Infarction; D009573:Nitrites / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010477:Perfusion; D010827:Physiology / Q000295:instrumentation; D013325:Strontium Isotopes; D014665:Vasodilator Agents
D002564:Cerium Isotopes; D009573:Nitrites; D013325:Strontium Isotopes; D014665:Vasodilator Agents; D000628:Aminophylline; D000255:Adenosine Triphosphate; D010208:Papaverine